Ameriprise’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.32M Sell
78,695
-7,362
-9% -$652K ﹤0.01% 2171
2025
Q4
$6.91M Sell
86,057
-32,076
-27% -$2.69M ﹤0.01% 2198
2025
Q3
$11.5M Sell
118,133
-4,218
-3% -$340K ﹤0.01% 1813
2025
Q2
$8.53M Buy
122,351
+22,565
+23% +$1.29M ﹤0.01% 1937
2025
Q1
$4.96M Sell
99,786
-2,184
-2% -$138K ﹤0.01% 2325
2024
Q4
$7.12M Sell
101,970
-505,848
-83% -$42M ﹤0.01% 2073
2024
Q3
$63.7M Sell
607,818
-4,141
-0.7% -$484K 0.02% 735
2024
Q2
$87M Buy
611,959
+104,441
+21% +$12M 0.02% 571
2024
Q1
$56.6M Sell
507,518
-18,478
-4% -$2.2M 0.02% 753
2023
Q4
$68.2M Buy
525,996
+78,127
+17% +$10.8M 0.02% 652
2023
Q3
$73M Buy
447,869
+47,133
+12% +$8.29M 0.02% 602
2023
Q2
$73.5M Sell
400,736
-166,508
-29% -$24M 0.02% 609
2023
Q1
$75.6M Buy
567,244
+439,443
+344% +$51.6M 0.02% 591
2022
Q4
$10.1M Sell
127,801
-6,345
-5% -$447K ﹤0.01% 1734
2022
Q3
$8.12M Sell
134,146
-7,086
-5% -$458K ﹤0.01% 1857
2022
Q2
$7.75M Buy
141,232
+1,116
+0.8% +$64.7K ﹤0.01% 1954
2022
Q1
$10.6M Buy
140,116
+113
+0.1% +$7.72K ﹤0.01% 1875
2021
Q4
$10.4M Sell
140,003
-1,048
-0.7% -$62.1K ﹤0.01% 1958
2021
Q3
$6.63M Sell
141,051
-5,609
-4% -$244K ﹤0.01% 2185
2021
Q2
$5.93M Sell
146,660
-3,982
-3% -$165K ﹤0.01% 2336
2021
Q1
$6.19M Buy
150,642
+7,227
+5% +$270K ﹤0.01% 2260
2020
Q4
$4.18M Sell
143,415
-5,242
-4% -$136K ﹤0.01% 2391
2020
Q3
$3.27M Sell
148,657
-3,794
-2% -$96.7K ﹤0.01% 2369
2020
Q2
$4.25M Sell
152,451
-4,735
-3% -$115K ﹤0.01% 2179
2020
Q1
$2.88M Sell
157,186
-16,508
-10% -$384K ﹤0.01% 2269
2019
Q4
$4.18M Sell
173,694
-4,730
-3% -$99.6K ﹤0.01% 2342
2019
Q3
$3.05M Sell
178,424
-280
-0.2% -$4.47K ﹤0.01% 2471
2019
Q2
$2.69M Sell
178,704
-30,925
-15% -$552K ﹤0.01% 2580
2019
Q1
$4.22M Buy
209,629
+17,585
+9% +$357K ﹤0.01% 2330
2018
Q4
$3.42M Buy
192,044
+6,606
+4% +$117K ﹤0.01% 2374
2018
Q3
$3.64M Buy
185,438
+7,064
+4% +$146K ﹤0.01% 2548
2018
Q2
$3.53M Buy
178,374
+9,238
+5% +$203K ﹤0.01% 2463
2018
Q1
$4.16M Sell
169,136
-29,401
-15% -$773K ﹤0.01% 2301
2017
Q4
$5.7M Buy
198,537
+147,408
+288% +$4.64M ﹤0.01% 2035
2017
Q3
$1.4M Sell
51,129
-27,609
-35% -$611K ﹤0.01% 2803
2017
Q2
$1.65M Buy
78,738
+60,784
+339% +$1.28M ﹤0.01% 2699
2017
Q1
$337K Sell
17,954
-72,575
-80% -$1.14M ﹤0.01% 3304
2016
Q4
$1.32M Sell
90,529
-25,024
-22% -$341K ﹤0.01% 2830
2016
Q3
$1.53M Sell
115,553
-41,523
-26% -$482K ﹤0.01% 2710
2016
Q2
$1.69M Sell
157,076
-156,250
-50% -$1.68M ﹤0.01% 2612
2016
Q1
$3.51M Sell
313,326
-88,730
-22% -$907K ﹤0.01% 2195
2015
Q4
$4.17M Sell
402,056
-26,160
-6% -$278K ﹤0.01% 2157
2015
Q3
$4.57M Sell
428,216
-136,675
-24% -$1.67M ﹤0.01% 2074
2015
Q2
$6.69M Sell
564,891
-308
-0.1% -$3.57K ﹤0.01% 1931
2015
Q1
$5.38M Sell
565,199
-173,110
-23% -$1.79M ﹤0.01% 2063
2014
Q4
$7.56M Buy
738,309
+198,971
+37% +$1.73M ﹤0.01% 1745
2014
Q3
$4.29M Buy
539,338
+332,498
+161% +$2.5M ﹤0.01% 2119
2014
Q2
$1.66M Hold
206,840
﹤0.01% 2597
2014
Q1
$1.78M Hold
206,840
﹤0.01% 2528
2013
Q4
$2.02M Sell
206,840
-1,713
-0.8% -$15.6K ﹤0.01% 2461
2013
Q3
$1.76M Hold
208,553
﹤0.01% 2504
2013
Q2
$1.52M Buy
+208,553
New +$1.21M ﹤0.01% 2476

Other funds holding ACLS

Ameriprise's ACLS Position: Q1 2026 in Review

Ameriprise reduced its Axcelis (ACLS) stake by 8.6% in Q1 2026, selling an estimated $652K and leaving 78,695 shares worth $7.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Ameriprise first reported a position in ACLS in Q2 2013 and has held it in 52 quarters since. The position peaked at $87M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Ameriprise held 78,695 shares of Axcelis worth $7.32M as of Q1 2026.
  • Ameriprise sold 7,362 Axcelis shares in Q1 2026, an estimated $652K.
  • Axcelis made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2171 holding.
  • Ameriprise first reported a position in Axcelis in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Axcelis position peaked at $87M in Q2 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.